Delivery Order SPE2DB22D2214-SPE2DB25FS6DA
- Not listed
- The Defense Logistics Agency awarded a $11,751.35 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of TREMFYA 100 mg/ml (one-press ml unit). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 20, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $14,691.41 to AmerisourceBergen Drug Corp for TREMFYA 100 MG/ML, a prescription pharmaceutical product. The contract, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, utilizes firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded. Performance will occur at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $14,510.52 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for TREMFYA 200 mg/2 mL pen injections. This contract, classified as a firm fixed price delivery order with no set-aside designation, is scheduled for completion by September 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. TREMFYA is a biologic immunosuppressant medication used to treat psoriasis and psoriatic...
- The Defense Logistics Agency awarded a $21,765.75 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of TREMFYA 200 mg/2 mL pen injections. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 28, 2025. The pharmaceutical product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,720.27 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml, a pharmaceutical product, with an ultimate completion date of August 19, 2025. This competitive award, issued on August 18, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TREMFYA 200 mg/2 mL pen injections on September 12, 2025, with a ceiling value of $7,255.25 and a firm fixed price structure. This is a non-set-aside competitive award, with performance to be completed by October 3, 2025, at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction within a larger pharmaceutical supply relationship between the contractor...
- The Defense Logistics Agency awarded a $19,006 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml pharmaceutical products on August 5, 2025, with an ultimate completion date of August 6, 2025. This non-set-aside competitive award is performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order valued at $7,269.70 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml syringes on August 18, 2025, with completion scheduled for August 19, 2025. This competitive award, which carries no set-aside designation, represents a firm fixed-price delivery order to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. TREMFYA is a biologic medication used to treat plaque psoriasis and other inflammatory...
- The Defense Logistics Agency awarded a $7,255.25 delivery order to AmerisourceBergen Drug Corp for TREMFYA 100 mg/mL, a pharmaceutical product, with an ultimate completion date of September 2, 2025. This non-set-aside contract utilizes firm fixed price pricing and represents a child delivery order under a larger contract vehicle. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $7,255.25 to AmerisourceBergen Drug Corp for TREMFYA 100 MG/ML, a pharmaceutical product, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order issued without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB25FS6DADelivery Order
The Defense Logistics Agency awarded a $42,749.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of TREMFYA 100 mg/ml injectable medication. The order, which represents a child contract under a larger indefinite delivery vehicle, was competitively awarded without set-aside provisions and carries an ultimate completion date of August 13, 2025. Performance will be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical supplies to support military healthcare systems and federal medical procurement needs. TREMFYA, a specialty pharmaceutical product, falls within the company's portfolio of brand-name and generic medications delivered across the Defense Health Agency and other government healthcare systems. The contract reflects DLA's ongoing pharmaceutical procurement strategy to maintain critical medical supply inventory for military personnel and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $42.7k | 8/12/25 |